Japan · Delayed Price · Currency is JPY Kao Corporation Earnings Call Transcripts
Fiscal Year 2026
-
AI is reshaping the customer journey, making scientific evidence and trusted quality key to brand selection. Global Marketing i-Kao enables predictive analytics and rapid scaling of best practices, while agile, data-driven marketing in EMEA accelerates global growth and efficiency.
-
Q1 saw strong sales and profit growth, with operating income up JPY 14 billion year-over-year and robust gains in Japan's GC Business. Full-year guidance is maintained despite external risks, and profit recovery is expected in Chemicals from Q2.
Fiscal Year 2025
-
Fiscal 2025 delivered strong sales and profit growth, with improved margins and ROIC, driven by robust performance in Japan and recovery in key overseas segments. Fiscal 2026 guidance projects continued growth, supported by new product launches, digital transformation, and strategic capital allocation.
-
Earnings for the nine months ended September 2025 showed strong sales and profit growth, with operating margin and ROIC both at 9.3%. Cosmetics and GC businesses led recovery, while cost controls and price increases offset raw material pressures.
-
Aims to become the top choice in targeted cosmetics categories by leveraging scientific and emotional brand strengths, focusing on six global brands, and implementing unified operations. Targets JPY 400 billion in sales and 15% operating margin by 2027, with strong growth in Japan, ASEAN, and a renewed strategy for China.
-
Solid first-half results led to upward revisions in full-year forecasts for sales and operating income, driven by strong performance in Japan, successful product launches, and ongoing structural reforms. Share repurchase and improved capital efficiency further support growth ambitions.
-
First quarter saw strong sales and margin growth, with operating income up 38.7% year-over-year. Cosmetics and UV Care segments drove performance, while tariff and raw material risks are being actively managed. Full-year guidance is maintained.
Fiscal Year 2024
-
Strong profit recovery in 2024 was driven by higher value-added products, cost reductions, and improved brand loyalty, with all key metrics exceeding expectations. 2025 guidance anticipates continued growth, especially in cosmetics and global expansion, despite rising raw material costs and ongoing challenges in China.
-
Structural reforms and high-value-added product strategies drove strong profit and margin growth, with ROIC up 4.9 points and operating income up 42.8% year-over-year. China cosmetics remains a drag, but gains from business transfers and global expansion support positive outlook.
-
First-half profit surged 68% year-over-year, driven by structural reforms and high-value-added products, with strong gains in core brands and chemicals. Full-year operating income forecast was raised to JPY 140 billion, but China cosmetics remain a drag.
-
Digital investment aligns with industry averages, with a shift toward aggressive DX expansion and operational efficiency. Key strengths include a robust data lake, empowered citizen developers, and a company-wide DX skill program. Initiatives focus on data-driven management, customer experience, and rapid global expansion.